Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-paclitaxel + cisplatin versus gemcitabine + cisplatin as first-line chemotherapy for advanced biliary tract cancer
ChiCTR1900028328Phase 2Recruiting
- Sponsor
- Tongji Hospital
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of paclitaxel, cisplatin and gemcitabine in biliary cancer (2 arms), sponsored by Tongji Hospital. Primary endpoint: progression-free survival. Started Dec 2019; status: recruiting.
02
Drugs
paclitaxelcisplatingemcitabine
03
Conditions
biliary cancer
Beyond the preview
Go deeper on ChiCTR1900028328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028328.